Skip to main content

CORRECTION article

Front. Pharmacol., 05 February 2020
Sec. Translational Pharmacology

Corrigendum: Genotype–Phenotype Association Analysis Reveals New Pathogenic Factors for Osteogenesis Imperfecta Disease

Jingru Shi&#x;Jingru Shi1†Meng Ren&#x;Meng Ren1†Jinmeng JiaJinmeng Jia1Muxue TangMuxue Tang1Yongli Guo,,*Yongli Guo2,3,4*Xin Ni,,*Xin Ni2,3,4*Tieliu Shi,*Tieliu Shi1,2*
  • 1Center for Bioinformatics and Computational Biology, and the Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China
  • 2Big Data and Engineering Research Center, Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, National Center for Children's Health, Beijing Pediatric Research Institute, Capital Medical University, Beijing, China
  • 3Biobank for Clinical Data and Samples in Pediatrics, Beijing Children's Hospital, National Center for Children's Health, Beijing Pediatric Research Institute, Capital Medical University, Beijing, China
  • 4Department of Otolaryngology, Head and Neck Surgery, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing, China

A Corrigendum on
Genotype–Phenotype Association Analysis Reveals New Pathogenic Factors for Osteogenesis Imperfecta Disease

by Shi J, Ren M, Jia J, Tang M, Guo Y, Ni X and Shi T. (2019). Front. Pharmacol. 10:1200. doi: 10.3389/fphar.2019.01200

There is an error in the Funding statement. The correct number for “Beihang University & Capital Medical University Advanced Innovation Center for Big Data-Based Precision Medicine Plan is “BHME- 201804.”

Additionally, in the original article, there was one error. In the Discussion section, the locations of the four candidate pathogenic variations in COL1A1 were incorrectly mapped to the major ligand-binding region (MLBR3).

A correction has been made to the Discussion, Paragraph five:

“To validate the pathogenicity of the candidate variations in COL1A1, we checked the specificity of their locations (positions of the four candidate mutations: 1094 and 1097). Evidence from the protein families database (Pfam) (El-Gebali et al., 2019) demonstrate that the locations of all four variations belong to the collagen triple helix region (PF01391: Collagen triple helix repeat (1079–1137)). Structurally, different abnormalities in the collagen helix are associated with the identity of the residue replacing Gly (Bryan et al., 2011; Qiu et al., 2018), which also influence the severity of OI patients (residues replacing Gly of four candidate mutations: Asp, Arg, and Ser). Through the statistical analysis on the location of Glysubstitution mutations in a large number of OI patients, Beck et al. found that all Gly→Asp in the α1(l) chain led to OI type II (perinatal lethat form) (Beck et al., 2000). In addition, the study of the impact of various Gly replacements discovered that the three replaced form (Gly→Arg, Gly→Ser, and Gly→Cys) had a stronger association with OI lethality than the other replaced forms (Beck et al., 2000). In all, these conclusions indicate that the four candidate mutations of COL1A1 we identified are highly likely to cause lethal OI phenotypes.”

Due to the error outlined above, the citations for “Di Lullo et al., 2002” and “Xiao et al., 2015” have been removed from the reference list, and “El-Gebali et al., 2019” has been cited instead.

The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.

References

Beck, K., Chan, V. C., Shenoy, N., Kirkpatrick, A., Ramshaw, J. A., Brodsky, B. (2000). Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine. Proc. Natl. Acad. Sci. U. S. A. 97 (8), 4273–4278. doi: 10.1073/pnas.070050097

PubMed Abstract | CrossRef Full Text | Google Scholar

Bryan, M. A., Cheng, H., Brodsky, B. (2011). Sequence environment of mutation affects stability and folding in collagen model peptides of osteogenesis imperfecta. Biopolymers 96 (1), 4–13. doi: 10.1002/bip.21432

PubMed Abstract | CrossRef Full Text | Google Scholar

Di Lullo, G. A., Sweeney, S. M., Korkko, J., Ala-Kokko, L., San Antonio, J. D. (2002). Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J. Biol. Chem. 277 (6), 4223–4231. doi: 10.1074/jbc.M110709200

PubMed Abstract | CrossRef Full Text | Google Scholar

El-Gebali, S., Mistry, J., Bateman, A., Eddy, S. R., Luciani, A., Potter, S. C., et al. (2019). The Pfam protein families database in 2019. Nucleic Acids Res. 47 (D1), D427–D432. doi: 10.1093/nar/gky995

PubMed Abstract | CrossRef Full Text | Google Scholar

Qiu, Y., Mekkat, A., Yu, H., Yigit, S., Hamaia, S., Farndale, R. W., et al. (2018). Collagen Gly missense mutations: effect of residue identity on collagen structure and integrin binding. J. Struct. Biol. 203 (3), 255–262. doi: 10.1016/j.jsb.2018.05.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Xiao, J., Yang, Z., Sun, X., Addabbo, R., Baum, J. (2015). Local amino acid sequence patterns dominate the heterogeneous phenotype for the collagen connective tissue disease osteogenesis imperfecta resulting from Gly mutations. J. Struct. Biol. 192 (1), 127–137. doi: 10.1016/j.jsb.2015.05.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: osteogenesis imperfecta, genotype, phenotype, novel candidate pathogenic genes, novel candidate pathogenic variations

Citation: Shi J, Ren M, Jia J, Tang M, Guo Y, Ni X and Shi T (2020) Corrigendum: Genotype–Phenotype Association Analysis Reveals New Pathogenic Factors for Osteogenesis Imperfecta Disease. Front. Pharmacol. 10:1603. doi: 10.3389/fphar.2019.01603

Received: 30 October 2019; Accepted: 10 December 2019;
Published: 05 February 2020.

Edited and reviewed by: Roberto Paganelli, Università degli Studi G. d'Annunzio Chieti e Pescara, Italy

Copyright © 2020 Shi, Ren, Jia, Tang, Guo, Ni and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yongli Guo, guoyongli@bch.com.cn; Xin Ni, nixin@bch.com.cn; Tieliu Shi, tlshi@bio.ecnu.edu.cn

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.